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The aim of this study was to microencapsulate Bifidobacterium longum subsp. infantis CCUG 25 52486 using the extrusion method in a variety of matrices, namely sodium alginate (SA), 26 sodium alginate-cow milk (SACM), sodium alginate-goat milk (SAGM) and sodium alginate-27 casein hydrolysate (SACH), and to evaluate the survival of free and encapsulated bacterial cells 28 under different conditions. The encapsulation yield, size and surface morphology of the 29 microcapsules were evaluated. The survival of microencapsulated bacterial cells and free 30 bacterial cells were evaluated under simulated gastrointestinal conditions as well as in 31 refrigeration, cow milk and goat milk during storage at 4 o C for 28 days. The average size of 32 SACM capsules and SAGM capsules was 2.8±0.3 mm and 3.1±0.2 mm respectively. Goat 33 milk and cow milk based matrices resulted in dense microcapsules which led to better 34 performances in simulated gastrointestinal conditions than SA and SACH microcapsules. The 35 bacterial cells encapsulated in SAGM showed the highest survival rate in cow milk (7.61 log 36 cfu g -1
Introduction
47
Bifidobacteria are a major group of probiotic microorganisms, which have been widely 48 researched for their probiotic properties. Bifidobacteria are considered to exert many beneficial 49 effects to the human host such as alleviation of lactose intolerance, reduction of serum 50 cholesterol levels, synthesis of some vitamins, prevention of colonization of pathogens, 51 modulation of the immune system, reduction of symptoms of irritable bowel disease, and 52 prevention of diarrhoea (Shah, 2007; Xiao et al., 2003) . They have been shown to be suitable 53 for incorporation as a co-starter in different food products including dairy-based food 54
formulations (Bunesova et al., 2015; Prasanna et al., 2014) . The therapeutic concentration of 55 probiotic bacteria in a product should be around 6 log CFU g−1 until the end of their shelf life 56 (Donkor et al., 2006) . In addition, bifidobacteria must endure the high acidic condition in the 57 stomach and hydrolytic enzymes and bile salts in the small intestine prior to reaching the colon 58 in large quantities, which is essential for effective permanent or transient colonization of 59 bacteria (Song et al., 2013) . Furthermore, most strains of bifidobacteria show poor growth and 60 viability in milk and fermented milk products (Ranadheera et al., 2014) . 61
62
In this context, microencapsulation has been widely researched to create a physical barrier 63 protecting the bacteria from adverse conditions during production processes and digestion 64 (Fritzen-Freire et al., 2012) . There are many microencapsulation techniques which have been 65 used with probiotics such as emulsion, extrusion, spray drying, freeze drying, coacervation, 66 fluidized bed coating and phase separation (Rajam et al., 2012) . Most of these techniques 67 involve harsh processing conditions, which directly affect the viability and the performances 68 of the encapsulated probiotic bacteria. However, the extrusion method involves mild conditions 69 during probiotic encapsulation (Shi et al., 2013a) . In this method, a hydrocolloid solution 70 containing concentrated probiotic bacteria is dropped into a solidifying solution. Sodium 71 alginate obtained from brown seaweed has been widely researched as an encapsulation material 72 for probiotics. However, alginate cannot protect effectively probiotic bacteria from the highly 73 acidic environment due to the porous structure of alginate beads, which supports the easy 74 diffusion of acid and other materials inside (Rajam et al., 2012) . Therefore, it is recommended 75 to blend or coat alginate with other filler materials to overcome the above-mentioned 76 disadvantages (Cook et al., 2013) . 77 microencapsulation of probiotic, such as alginate-starch (Sultana et al., 2000) , alginate-80 chitosan (Chávarri et al., 2010; Krasaekoopt et al., 2004 ), alginate-gelatin (Li et al., 2009 , 81 alginate-pectin (Sandoval-Castilla et al., 2010) and alginate-whey protein (Gbassi et al., 2009) . 82
In addition, there has been a considerable interest in using dairy-based matrices to encapsulate 83 probiotic bacteria, since these materials contain lactose and proteins which can provide good 84 protection for cells during the handling and digestion process (Maciel et al., 2014) . Milk and 85 milk proteins are used in many food formulations and are widely accepted by consumers due 86 to unique physicochemical properties. In the context of encapsulation, milk and milk proteins 87 have technological properties such as high buffering capacity, good emulsification properties 88 and the ability to make networks, even at low concentration (Würth et al., 2015) . In addition, 89 it is reported that microcapsules containing dairy proteins can lead to higher bacterial survival 90 during digestion (Burgain et al., 2014) . Furthermore, usage of milk based materials for 91 encapsulation of microorganisms would be suitable to be used in dairy-based food products 92 with improved physicochemical properties (Ranadheera et al., 2016) . Therefore, there is a high 93 potential to use different milk types and milk based proteins with alginate to encapsulate, 94 protect and control the release of probiotic bacteria in the digestive tract (Özer et al., 2009; 95 Ranadheera et al., 2015) . 96
However, there are few recorded reports on the effect of different alginate-dairy based matrices 97 on encapsulation of bifidobacteria. In addition, to the best of authors' knowledge goat milk has 98 not been used with alginate to encapsulate bifidobacteria using the extrusion technique. 99 Therefore, the aim of this study was to evaluate the survival of Bifidobacterium longum subsp. 100 infantis CCUG 52486 encapsulated in sodium alginate, sodium alginate-cow milk, sodium 101 alginate-goat milk and sodium alginate-casein hydrolysate in simulated gastrointestinal 102 conditions and during storage in cow milk, goat milk and refrigeration at 4 o C for 28 days. This 103
Bifidobacterium strain was selected as in our previous studies, it was shown to produce an 104 exopolysaccharide (EPS) in milk (Prasanna et al., 2012) and to improve the physicochemical 105 and rheological properties of low-fat set yoghurt (Prasanna et al., 2013) . In addition, this strain 106 has been characterized as a probiotic strain (Gougoulias et al., 2008) Samples of free B. longum subsp. infantis cells were serially diluted in PBS (Oxoid, UK) and 150 100 µL aliquots were plated on BSM agar (Sigma-Aldrich, UK) to enumerate the viable 151 bacterial counts. The plates were incubated under anaerobic conditions at 37 °C for 72 h. In 152 the case of encapsulated bacteria, the samples were completely dissolved in sterilized 50 mM 153 sodium citrate (Sigma-Aldrich, UK) solution at pH 7.5 before plating as described by Shi et al. 154 (2013a) . For this, 1 g of the encapsulated bacteria was dissolved in 9 mL sodium citrate and 155 the samples were serially diluted in PBS (Oxoid, UK). Aliquots of 100 µL of the serially diluted 156 sample were plated on BSM agar (Sigma-Aldrich, UK) and after incubation, the viable cell 157 counts were enumerated. 158
159
Survival of free and encapsulated bacteria in simulated gastrointestinal conditions 160
Simulated gastric juice (SGJ) was prepared by dissolving 0.2% NaCl (w/v) in 0.08 M HCl, at 161 pH 2 as described by Sun and Griffiths (2000) . The microcapsules (1 g) or the free cells (1 mL) 162 were added to glass tubes containing 9 mL of sterilized SGJ and placed in a water bath at 37 163 o C. Samples were taken at 0, 30, 60 and 120 min, during incubation. For the free cells, the 164 samples were taken and centrifuged at 10,000 rpm for 10 min, at 4 °C. The pellet was dissolved 165 in PBS (Oxoid, UK) and used for cell enumeration. In the case of microencapsulated bacterial 166 cells, the microcapsules were separated from the samples and dissolved in sodium citrate (50 167 mM) before plating. For enumeration, all samples were serially diluted in PBS (Oxoid, UK) 168 and viable cells were enumerated as described in Section 2.4. 169 
Scanning electron microscopic (SEM) analysis of surface of microcapsules 192
The microcapsules were dehydrated sequentially in a series of ethanol solutions (30, 50, 70, 193 80, 90, and 100%) . For this, the microcapsules were soaked for 15 minutes in each solution. 194
The dehydrated microcapsules were critical point dried using a critical point dryer (Balzers 195 CPD 030, Liechtenstein, Germany) with liquid carbon dioxide. The dried samples were fixed 196 to the SEM stubs with double-sided tape. Afterward, the microcapsules were gold coated using 197
an Edwards S150B sputter-coater for 2.5 min (Edwards, West Sussex, UK). The surface of 198 coated microcapsules was examined using a scanning electron microscope (FEI, Quanta 600 199 Pan et al. (2013) who reported around 99% of the encapsulation efficiency of 228 bacteria with alginate-skim milk. The results clearly showed that there was a very low loss of 229 cell viability during the encapsulation which was due to the mild conditions used. In general, 230 extrusion method is commonly used with hydrocolloids and reported to yield higher 231 encapsulation yield (Krasaekoopt et al., 2003) . 232 233 The surface morphology of the microcapsules was investigated using SEM micrographs. Fig.1  234 shows the surface of different microcapsules at a magnification of 10000. Porous 235 microcapsules were observed with SA [ Fig.1 (A) ]. Furthermore, SA microcapsules had cracks 236 on their surface and could not protect entrapped cells from adverse environmental conditions. 237
Similarly, Li et al. (2009) 
Survival of free and encapsulated bacterial cells in cow milk and goat milk at 4
o C 323 Table 2 shows the survival of free and encapsulated stored in cow milk at 4 o C for 28 days. 324
The results indicated that encapsulation improved the survival of bacterial cells in cow milk 325 during storage. The free cells showed poor storage stability in cow milk where the cell 326 concentration was significantly (p<0.05) reduced from 8.65 log cfu mL -1 to 4.38 log cfu mL -1 327 within 28 days. SAGM microcapsules gave the best protection for the cells followed by SACM 328 microcapsules. However, SA and SACH microcapsules could give a limited protection during 329 the storage in cow milk. was observed with SAGM microcapsules followed by SACM microcapsules; where they 335 maintained the viability of bacterial cells above 6 log cfu g -1 in goat milk during the storage 336 period. Viable cell counts of SA and SACH microcapsules rapidly declined with the storage. 337
338
Poor viability of free cells in cow milk and goat milk is due to lack of availability of small 339 peptides and free amino acids for their growth (Gomes et al., 1998; Martıń-Diana et al., 2003) . 340
In this study, pure goat milk and cow milk were used to inoculate bacteria without any 341 , 15, 116-125. 526 Xiao, J., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hiramatsu, A., Iwatsuki, K., 527 Kokubo, S., & Hosono, A. (2003) . Effects of milk products fermented by 528
Foods
Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. 529 Science, 86(7), 2452 Science, 86(7), -2461 Zou, Q., Zhao, J., Liu, X., Tian, F., Zhang, H., Zhang, H., & Chen, W. (2011) . Mean values (±standard deviation) within the same column not sharing a common superscript 587 differ significantly (P < 0.05). SA: microcapsules were prepared using alginate. SACM: 588 microcapsules were produced using alginate and cow milk at a ratio of 1.5:1 (v/v). SAGM: 589 microcapsules were produced using alginate and goat milk at a ratio of 1.5:1 (v/v). SACH: 590 microcapsules were prepared using alginate and casein hydrolysate at a ratio of 1.5:1 (v/v). 591 592 593 
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